Conclusion: The recombined vaccine can induce specific cellular immune response in vitro and suppress HPV16 positive TC-1 tumor cell growth obviously in vivo.

• 结论：该疫苗能激发特异性细胞免疫反应；显著抑制HPV16转化的TC-1肿瘤细胞生长。